ENERTIME (EPA:ALENE) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Home
Companies
ENERTIME

BRIEF

published on 10/09/2024 at 18:05, 1 month 11 days ago

ENERTIME in receivership: end of activities

Renewable Energy Financial Difficulties ENERTIME Commercial Court Compulsory Liquidation
BRIEF

published on 09/18/2024 at 18:05, 2 months 2 days ago

ENERTIME, Update on the Judicial Reorganization Procedure

Investors Job ENERTIME Quoting Judicial Recovery
BRIEF

published on 08/08/2024 at 17:50, 3 months 12 days ago

ENERTIME: Modification of the Date of the 2024 General Meeting

Shareholders General Assembly Energetic Efficiency ENERTIME Date Change
BRIEF

published on 07/25/2024 at 18:05, 3 months 26 days ago

ENERTIME: ORDINARY AND EXTRAORDINARY GENERAL MEETING 2024

Shareholders Resolutions General Assembly Quorum ENERTIME
BRIEF

published on 07/10/2024 at 16:10, 4 months 10 days ago

ENERTIME requests its placement in receivership

Renewable Energy Investors The Commercial Court Legal Redress ENERTIME
BRIEF

published on 07/02/2024 at 09:20, 4 months 19 days ago

ENERTIME: Postponement of the General Meeting and Suspension of Trading

Euronext General Assembly Trading Suspension ENERTIME
BRIEF

published on 06/11/2024 at 18:05, 5 months 9 days ago

ENERTIME Signs Representation Agreement in Taiwan and Expands in Asia

Energy Efficiency ENERTIME ORC Technology Tai-Fung Group Asia Expansion
PRESS RELEASE

published on 06/11/2024 at 18:00, 5 months 9 days ago

ENERTIME ANNOUNCES THE SIGNING OF A REPRESENTATION AGREEMENT IN THE ISLAND OF TAIWAN AND PROVIDES AN UPDATE ON ITS COMMERCIAL DEVELOPMENT IN ASIA
French 'Cleantech' company Enertime signs exclusive representation agreement with Tai-Fung Group in Taiwan, expanding into Asian market for energy efficiency solutions

Cleantech ENERTIME Tai-Fung Group Energy Efficiency Solutions Asian Market
BRIEF

published on 06/11/2024 at 08:05, 5 months 10 days ago

ENERTIME Signs a Representation Agreement for Taiwan and Strengthens its Presence in Asia

Cleantech Asia ORC ENERTIME Representation Agreement
BRIEF

published on 05/31/2024 at 18:20, 5 months 20 days ago

Availability of ENERTIME’s 2023 annual financial report

Financial Report 2023 Cleantech ENERTIME

Accesswire

Published on 11/21/2024 at 13:30, 13 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 13 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 43 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 43 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 43 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 28 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 8 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 28 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 37 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 43 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE